These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9877052)
1. Pulmonary haemorrhage in infants with gestational age of less than 30 weeks. De Carolis MP; Romagnoli C; Cafforio C; Piersigilli F; Papacci P; Vento G; Tortorolo G Eur J Pediatr; 1998 Dec; 157(12):1037-8. PubMed ID: 9877052 [No Abstract] [Full Text] [Related]
2. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study. Lamboley-Gilmert G; Lacaze-Masmonteil T; Paediatr Drugs; 2003; 5(9):639-45. PubMed ID: 12956620 [TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R; Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381 [TBL] [Abstract][Full Text] [Related]
5. On "A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants" (Am J Perinatol 2004;21:109-120). Bancalari E Am J Perinatol; 2004 Jul; 21(5):307-9. PubMed ID: 15232767 [No Abstract] [Full Text] [Related]
7. Have we been down this road before? Lutchman D J Perinatol; 2010 Oct; 30(10):698-9; author reply 698. PubMed ID: 20877366 [No Abstract] [Full Text] [Related]
8. Surfactant treatment for premature babies--a review of clinical trials. Morley CJ Arch Dis Child; 1991 Apr; 66(4 Spec No):445-50. PubMed ID: 2025043 [No Abstract] [Full Text] [Related]
9. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. van Houten J; Long W; Mullett M; Finer N; Derleth D; McMurray B; Peliowski A; Walker D; Wold D; Sankaran K J Pediatr; 1992 Feb; 120(2 Pt 2):S40-4. PubMed ID: 1735851 [TBL] [Abstract][Full Text] [Related]
10. Choosing a right surfactant for respiratory distress syndrome treatment. Ramanathan R Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858 [TBL] [Abstract][Full Text] [Related]
11. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Ardell S; Pfister RH; Soll R Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996 [TBL] [Abstract][Full Text] [Related]
12. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R; Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380 [TBL] [Abstract][Full Text] [Related]
13. Clinical trials of synthetic surfactant in the respiratory distress syndrome of premature infants. Corbet A Clin Perinatol; 1993 Dec; 20(4):737-60. PubMed ID: 8131365 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary pathology in surfactant-treated preterm infants with respiratory distress syndrome: an autopsy study. Toti P; Buonocore G; Rinaldi G; Catella AM; Bracci R Biol Neonate; 1996; 70(1):21-8. PubMed ID: 8853843 [TBL] [Abstract][Full Text] [Related]
15. Retrospective search for bleeding diathesis among premature newborn infants with pulmonary hemorrhage after synthetic surfactant treatment. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. Long W; Corbet A; Allen A; McMillan D; Boros S; Vaughan R; Gerdes J; Houle L; Edwards K; Schiff D J Pediatr; 1992 Feb; 120(2 Pt 2):S45-8. PubMed ID: 1735852 [TBL] [Abstract][Full Text] [Related]
16. Clinical trials of natural surfactant extract in respiratory distress syndrome. Mercier CE; Soll RF Clin Perinatol; 1993 Dec; 20(4):711-35. PubMed ID: 8131364 [TBL] [Abstract][Full Text] [Related]
18. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Pfister RH; Soll RF; Wiswell T Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826 [TBL] [Abstract][Full Text] [Related]
19. Animal-derived surfactant treatment of respiratory distress syndrome in premature neonates: a review. Fujii AM; Carillo M Drugs Today (Barc); 2009 Sep; 45(9):697-709. PubMed ID: 19956811 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Soll RF; Morley CJ Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]